These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37589417)
21. Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer. Lu X; Wang J; Wang W; Lu C; Qu T; He X; Liu X; Guo R; Zhang E Oncogene; 2022 Jun; 41(23):3222-3238. PubMed ID: 35508543 [TBL] [Abstract][Full Text] [Related]
22. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3. Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer. Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625 [TBL] [Abstract][Full Text] [Related]
24. The HIFIA/LINC02913/IGF1R axis promotes the cell function of adipose-derived mesenchymal stem cells under hypoxia via activating the PI3K/AKT pathway. Xiong X; Yuan L; Yang K; Wang X J Transl Med; 2023 Oct; 21(1):732. PubMed ID: 37848931 [TBL] [Abstract][Full Text] [Related]
25. RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA. Cui S; Li C Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907841 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis Li P; Xing J; Zhang J; Jiang J; Liu X; Zhao D; Zhang Y J Adv Res; 2020 Nov; 26():123-135. PubMed ID: 33133688 [TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA COL4A2-AS1 facilitates cell proliferation and glycolysis of colorectal cancer cells via miR-20b-5p/hypoxia inducible factor 1 alpha subunit axis. Yu Z; Wang Y; Deng J; Liu D; Zhang L; Shao H; Wang Z; Zhu W; Zhao C; Ke Q Bioengineered; 2021 Dec; 12(1):6251-6263. PubMed ID: 34477476 [TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258 [No Abstract] [Full Text] [Related]
29. Long noncoding RNA HIF1A-AS2 facilitates cell survival and migration by sponging miR-33b-5p to modulate SIRT6 expression in osteosarcoma. Lin H; Zhao Z; Hao Y; He J; He J Biochem Cell Biol; 2020 Apr; 98(2):284-292. PubMed ID: 31626739 [TBL] [Abstract][Full Text] [Related]
30. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer. Chen X; Liu M; Meng F; Sun B; Jin X; Jia C J Cell Biochem; 2019 Jan; 120(1):243-252. PubMed ID: 30216500 [TBL] [Abstract][Full Text] [Related]
31. circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop. Li X; Wang J; Lin W; Yuan Q; Lu Y; Wang H; Chen Y; Chen L; Dai P; Long H; Li X Mol Cancer; 2022 Jun; 21(1):135. PubMed ID: 35739524 [TBL] [Abstract][Full Text] [Related]
32. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway. Sun CC; Zhu W; Li SJ; Hu W; Zhang J; Zhuo Y; Zhang H; Wang J; Zhang Y; Huang SX; He QQ; Li DJ Genome Med; 2020 Sep; 12(1):77. PubMed ID: 32878637 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers. Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832 [TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. Yang K; Zhang W; Zhong L; Xiao Y; Sahoo S; Fassan M; Zeng K; Magee P; Garofalo M; Shi L Cell Death Differ; 2023 Jun; 30(6):1533-1549. PubMed ID: 37041291 [TBL] [Abstract][Full Text] [Related]
35. Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer. Liao TT; Chen YH; Li ZY; Hsiao AC; Huang YL; Hao RX; Tai SK; Chu PY; Shih JW; Kung HJ; Yang MH Cancer Immunol Res; 2024 Oct; 12(10):1468-1484. PubMed ID: 38920249 [TBL] [Abstract][Full Text] [Related]
36. A novel LncRNA HITT forms a regulatory loop with HIF-1α to modulate angiogenesis and tumor growth. Wang X; Li L; Zhao K; Lin Q; Li H; Xue X; Ge W; He H; Liu D; Xie H; Wu Q; Hu Y Cell Death Differ; 2020 Apr; 27(4):1431-1446. PubMed ID: 31700144 [TBL] [Abstract][Full Text] [Related]
37. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. Zeng Z; Xu FY; Zheng H; Cheng P; Chen QY; Ye Z; Zhong JX; Deng SJ; Liu ML; Huang K; Li Q; Li W; Hu YH; Wang F; Wang CY; Zhao G Theranostics; 2019; 9(18):5298-5314. PubMed ID: 31410216 [No Abstract] [Full Text] [Related]
38. Hypoxia activated long non-coding RNA HABON regulates the growth and proliferation of hepatocarcinoma cells by binding to and antagonizing HIF-1 alpha. Ma CN; Wo LL; Wang DF; Zhou CX; Li JC; Zhang X; Gong XF; Wang CL; He M; Zhao Q RNA Biol; 2021 Nov; 18(11):1791-1806. PubMed ID: 33478328 [TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α. Liu D; Li H Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988076 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway. Li X; Deng SJ; Zhu S; Jin Y; Cui SP; Chen JY; Xiang C; Li QY; He C; Zhao SF; Chen HY; Niu Y; Liu Y; Deng SC; Wang CY; Zhao G Oncotarget; 2016 Feb; 7(5):6000-14. PubMed ID: 26755660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]